MRNA is expected to report earnings to fall 51.65% to -161 cents per share on October 31
Q3'24
Est.
$-1.61
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.48
Q4'23
Beat
by $1.54
Q3'23
Missed
by $7.63
The last earnings report on August 01 showed earnings per share of -332 cents, beating the estimate of -334 cents. With 4.74M shares outstanding, the current market capitalization sits at 25.27B.